SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-18-010766
Filing Date
2018-07-31
Accepted
2018-07-31 21:40:28
Documents
1
Period of Report
2018-07-26

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5560
  Complete submission text file 0001493152-18-010766.txt   6893
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Issuer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1010 ATLANTIC AVENUE, SUITE 102 ALAMEDA CA 94501
Business Address
ANNETT WILLIAM (Reporting) CIK: 0001662553 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37648 | Film No.: 18982773